M. Hashimoto

Prebiotics affect nutrient digestibility but not faecal ammonia in dogs fed increased dietary protein levels

T. Inakuma, K. Oiwa, H. Suganuma, 2003, British Journal of Nutrition.

Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice

K. Oiwa, J. Yamamoto, T. Yamashita, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis

I. Kovács, J. Yamamoto, T. Yamashita, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Conjunctive Effects of the 5HT2 Receptor Antagonist, Sarpogrelate, on Thrombolysis with Modified Tissue Plasminogen Activator in Different Laser-Induced Thrombosis Models

J. Giddings, J. Yamamoto, T. Yamashita, 2000, Pathophysiology of Haemostasis and Thrombosis.

A new model to evaluate the diet-induced prothrombotic state, using He–Ne laser-induced thrombogenesis in the carotid artery of apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice

K. Oiwa, J. Yamamoto, Y. Ijiri, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The differential effects of aspirin on platelets, leucocytes and vascular endothelium in an in vivo model of thrombus formation.

J. Giddings, M. Hashimoto, J. Yamamoto, 1999, Clinical and laboratory haematology.

Adjuvant effect of antibodies against von Willebrand Factor, fibrinogen, and fibronectin on staphylokinase-induced thrombolysis as measured using mural thrombi formed in rat mesenteric venules.

J. Giddings, J. Yamamoto, T. Yamashita, 2000, Thrombosis research.

Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model

K. Oiwa, Y. Okada, K. Okada, 2003, Thrombosis and Haemostasis.

Enhanced endogenous thrombolysis induced by a specific factor Xa inhibitor, DX-9065a, evaluated in a rat arterial thrombolysis model in vivo.

K. Oiwa, J. Giddings, J. Yamamoto, 2002, Thrombosis Research.

Enhanced Thrombolysis Induced by Argatroban or Activated Protein C in the Presence or Absence of Staphylokinase, Measured in an in vivo Animal Model Using Mesenteric Arterioles

K. Oiwa, Y. Ohta, T. Kishi, 2001, Pathophysiology of Haemostasis and Thrombosis.

Enhancement of Endogenous Plasminogen Activator-induced Thrombolysis by Argatroban and APC and Its Control by TAFI, Measured in An Arterial Thrombolysis Model In Vivo Using Rat Mesenteric Arterioles

K. Oiwa, J. Giddings, J. Yamamoto, 2002, Thrombosis and Haemostasis.